2 research outputs found
Dupilumab reduced severe exacerbation rates and improved pre-bronchodilator Fev 1 in patients with moderate-to-severe asthma regardless of exacerbation history of è …1, è …2, or è …3 prior exacerbations: Liberty Asthma Traverse
This is the author accepted manuscript. The final version is available from the American Thoracic Society via the DOI in this record Sanofi and Regeneron Pharmaceuticals, Inc